Controversial autism drug gets ambitious new trial
The makers of a drug designed to correct an enzyme shortage seen in some children with autism are moving to test it in children with autism who do not have that deficiency.
The makers of a drug designed to correct an enzyme shortage seen in some children with autism are moving to test it in children with autism who do not have that deficiency.
Teaching parents of toddlers with autism how to respond to their children may result in long-term improvements in these children’s autism features.
Scientists test CRISPR as a cancer treatment, an app could help parents pick up on hints of autism, and a Dutch science academy tries to tilt its ranks toward women.
Researchers are grappling with the complexities of transforming oxytocin into a drug for use in the clinic.
Sports bring benefits to children on the spectrum, researchers debate sharing DNA data with study participants, and a look at the brain’s many genomes earns a prestigious prize.
A drug called atomoxetine eases hyperactivity in children who have both autism and attention deficit hyperactivity disorder.
Scientists can learn from ‘mentors’ with autism, schoolgirls on the spectrum pen a book about their experiences, and researchers spot clues that a paper’s authorship was purchased.
A set of seven standard tests can accurately assess cognitive capacities in people with various types of intellectual disability.
Some say a focus on basic neuroscience is crushing clinical research, a gene database gets a big upgrade, and Autism Speaks revises its goals.
It’s been 50 years since the first description of Rett syndrome, a hodgepodge of supplements sickens a boy with autism, and gender stereotypes make it hard to spot girls on the spectrum.